IL139616A0 - Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof - Google Patents

Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof

Info

Publication number
IL139616A0
IL139616A0 IL13961699A IL13961699A IL139616A0 IL 139616 A0 IL139616 A0 IL 139616A0 IL 13961699 A IL13961699 A IL 13961699A IL 13961699 A IL13961699 A IL 13961699A IL 139616 A0 IL139616 A0 IL 139616A0
Authority
IL
Israel
Prior art keywords
methods
iduronidase
recombinant
purifying
deficiencies
Prior art date
Application number
IL13961699A
Other languages
English (en)
Original Assignee
Harbor Ucla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbor Ucla filed Critical Harbor Ucla
Publication of IL139616A0 publication Critical patent/IL139616A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01076—L-Iduronidase (3.2.1.76)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
IL13961699A 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof IL139616A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7820998A 1998-05-13 1998-05-13
US17097798A 1998-10-13 1998-10-13
PCT/US1999/010102 WO1999058691A2 (en) 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

Publications (1)

Publication Number Publication Date
IL139616A0 true IL139616A0 (en) 2002-02-10

Family

ID=26760239

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13961699A IL139616A0 (en) 1998-05-13 1999-05-07 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof

Country Status (8)

Country Link
EP (1) EP1078075A2 (xx)
JP (1) JP2002514429A (xx)
CN (1) CN1300323A (xx)
AU (1) AU4072499A (xx)
BR (1) BR9910323A (xx)
CA (1) CA2328518A1 (xx)
IL (1) IL139616A0 (xx)
WO (1) WO1999058691A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585971B1 (en) * 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
US6569661B1 (en) * 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6426208B1 (en) * 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
EP2767291B1 (en) 2000-07-18 2016-09-14 Duke University Treatment of glycogen storage disease type II
US7442372B2 (en) * 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP2630241B1 (en) * 2010-10-22 2018-10-17 CuRNA, Inc. Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
CN103487414A (zh) * 2012-06-14 2014-01-01 北京和信非凡生物技术有限公司 一种α-L-艾杜糖醛酸酶活性检测方法、底物和试剂
DK2984166T3 (da) 2013-03-15 2020-07-20 Univ Pennsylvania Sammensætninger til behandling af mpsi
KR20180121899A (ko) 2016-02-03 2018-11-09 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 I형 점액다당류증을 치료하기 위한 유전자 요법
IL268076B1 (en) * 2017-01-31 2024-06-01 Regenxbio Inc Treatment of mucopolysaccharidoses I with human iduronidase L (IDUA) and full human glycosylations
BR112020000063A2 (pt) 2017-07-06 2020-07-14 The Trustees Of The University Of Pennsylvania terapia gênica mediada por aav9 para tratamento de mucopolissacaridose tipo i
CN107699590A (zh) * 2017-10-13 2018-02-16 成都中医药大学 一种制备重组人α‑L‑艾杜糖醛酸酶的方法
CN115109790A (zh) * 2021-03-23 2022-09-27 北京据德医药科技有限公司 一种重组a-L-艾杜糖醛酸普酶及其制备方法
CN114181318B (zh) * 2021-11-08 2023-08-01 四川大学 一种组织特异性表达穿透血脑屏障的idua融合蛋白的重组腺相关病毒及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2099503C (en) * 1991-11-14 2007-10-09 Hamish Steele Scott Synthetic alpha-l-iduronidase and genetic sequences encoding same
ES2326705T3 (es) * 1995-09-14 2009-10-16 Virginia Tech Intellectual Properties, Inc. Produccion de enzimas lisosomicas en sistemas de expresion basados en plantas.

Also Published As

Publication number Publication date
WO1999058691A3 (en) 2000-02-17
AU4072499A (en) 1999-11-29
CN1300323A (zh) 2001-06-20
WO1999058691A2 (en) 1999-11-18
EP1078075A2 (en) 2001-02-28
JP2002514429A (ja) 2002-05-21
BR9910323A (pt) 2001-01-30
CA2328518A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
IL146105A (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
IL115854A0 (en) Process for purifying and isolating 2'-deoxy-2',2'-difluoronucleosides
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
EP0785205A4 (en) 2-SILYLOXYTETRAHYDROTHIENOPYRIDINE, ITS SALT, AND ITS PRODUCTION METHOD
SG87108A1 (en) Monofilament and process for producing the same
AU5855498A (en) Monoolefinic c5-mononitriles, method for the production and the use thereof
EP1148078A4 (en) POLYIMIDE CONTAINING CROSSLINKABLE GROUP AND PROCESS FOR PRODUCING THE SAME
IL139616A0 (en) Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating, diseases caused by deficiencies thereof
EP0725137A4 (en) KETO GROUP INTRODUCTIVE ENZYME, ENCODING DNA, AND METHOD FOR PRODUCING KETOCAROTENOID
HK1008553A1 (en) Composite nonwoven, method for its production and its use
EP0911393A4 (en) METHOD FOR PRODUCING AND USING A NEW PEPTIDE
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
HU9700566D0 (en) Amino-alkyl- and acyl-amino-alkyl-ethers, process for producing them and their use as bradiquinine-receptor-antagonists
EP0693474A4 (en) NEW BENZYLAMINOETHOXYBENZENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
HUP0001837A3 (en) Novel dnas and process for producing proteins by using the same
IL113357A (en) Process for preparing alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O, S-esters
HUP0102772A3 (en) Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
SG83787A1 (en) Process for preparing phosphine oxides and process for purifying the same
HU9904564D0 (en) Substituted cycloheptenes, process for producing them and their use
ZA200006166B (en) Substituted sulphonyl cyanamides, method for producing same and their use as medicament.
IT1302971B1 (it) Procedimento di produzione per prosciutti, e mezzi relativi alprocedimento
EP1081159A4 (en) PURIFIED HUMAN ACTIVIN AND PROCESS FOR PRODUCING THE SAME
HUP0103106A3 (en) Method for producing 4,6-disubstituted 2-isocyanatopyrimidines and their use as intermediate
EP0962475A4 (en) AMIDATED POLYACETAL RESINS, THEIR PRODUCTION PROCESS AND THEIR USES
EP1111046A4 (en) NOVEL PROTEIN AND PROCESS FOR PRODUCING THE SAME